Ambrx Biopharma Inc.

NYSE:AMAM

28 (USD) • At close March 6, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 0.0531.1230.0242.2452.2451.2991.6131.1621.1622.5662.5663.5963.5963.243.24
Kosten van de omzet 000000000000000
Brutowinst 0.0531.1230.0242.2452.2451.2991.6131.1621.1622.5662.5663.5963.5963.243.24
Brutowinstmarge 111111111111111
Onderzoek- en ontwikkelingskosten 16.26914.3939.7510.27110.27118.06214.70416.10816.10811.0411.045.2485.2484.9694.969
Algemene en administratieve kosten 9.415.96.0655.5925.5924.8234.3964.3014.3014.1194.1191.8771.8771.1831.183
Verkoop- en marketingkosten 001.2540.6820.68200.9580.3480.3480.370.370.0380.0380.7020.702
Verkoop-, algemene en administratieve kosten 9.415.97.3196.2746.2744.8235.3544.6494.6494.4894.4891.9141.9141.8841.884
Overige kosten 0.0590.01-1.01342.932-0.126-0.144-0.784102.9560000000
Bedrijfskosten 25.67920.29316.056-15.944-15.94422.88519.274-20.696-20.696-15.224-15.224-9.493-9.493-6.276-6.276
Bedrijfsresultaat -25.626-19.17-16.032-8.669-8.669-28.781-17.661-17.875-19.048-12.651-12.651-3.535-3.535-3.023-3.023
Bedrijfsresultaat ratio -483.509-17.07-668-3.861-3.861-22.156-10.949-15.39-16.399-4.93-4.93-0.983-0.983-0.933-0.933
Totaal overige inkomsten en kosten netto 2.7851.6490.803-1.592.798-7.127-3.399-0.487-0.487-0.007-0.007-2.365-2.3650.0040.004
Inkomen voor belasting -22.841-17.521-15.229-13.143-13.143-28.713-21.06-19.535-19.535-12.658-12.658-5.9-5.9-3.019-3.019
Inkomen voor belasting ratio -430.962-15.602-634.542-5.854-5.854-22.104-13.056-16.818-16.818-4.933-4.933-1.641-1.641-0.932-0.932
Belastingkosten 0.1480.3050.0730.1110.1110.1291.5871.661.1730.0010.0010.6210.6210.0010.001
Nettowinst -22.989-17.826-15.302-13.254-13.254-28.842-22.647-21.194-19.535-14.505-14.505-5.554-5.554-2.718-2.718
Nettowinstmarge -433.755-15.874-637.583-5.904-5.904-22.203-14.04-18.247-16.818-5.653-5.653-1.545-1.545-0.839-0.839
WPA (Winst Per Aandeel) -0.37-0.32-0.34-0.34-0.34-0.75-0.59-1.04-0.51-5.72-5.72-0.41-0.41-0.14-0.14
Verwaterde WPA -0.37-0.32-0.34-0.34-0.34-0.75-0.59-1.04-0.51-5.72-5.72-0.41-0.41-0.14-0.14
EBITDA -25.105-20.23-15.966-8.793-8.793-23.631-17.103-18.462-18.462-12.161-12.161-3.052-3.052-2.535-2.535
EBITDA ratio -473.679-18.014-665.25-3.917-3.917-18.192-10.603-15.895-15.895-4.739-4.739-0.849-0.849-0.782-0.782